Products & Reviews

25

Product Filter

Drug discovery > Basic Research
Browse by Techniques
Agilent Technologies

Ratings

Search

Selected Filters:



96Pack Gold Competent Cells

Agilent Technologies

Highest efficiency competent cells in convenient packaging designed to satisfy higher throughput requirements. For ultimate convenience we offer custom configurations, formulations, and packaging options. Visit our custom & bulk services page, or contact your local sales specialist.

0.0/5.0
|0 Reviews

AAV-293 Cells

Agilent Technologies

The AAV Helper-Free System eliminates the requirement for wild-type adenovirus co-infection from both AAV vector production and AAV stock titering steps, making this system entirely helper virus-free and safer. 

0.0/5.0
|0 Reviews

AAV-HT1080 Cells

Agilent Technologies

The AAV Helper-Free System eliminates the requirement for wild-type adenovirus co-infection from both AAV vector production and AAV stock titering steps, making this system entirely helper virus-free and safer. 

0.0/5.0
|0 Reviews

ABLE C Competent Cells

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews

ABLE C Electroporation-Competent Cells

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews

ABLE Competent Cell Kit

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews

ABLE Electroporation-Competent Cell Kit

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews

ABLE K Electroporation-Competent Cells

Agilent Technologies

The ABLE C strain and the ABLE K strain help solve issues associated with toxic clones. The ABLE C strain reduces the copy number of ColE1-derived plasmids, e.g. pUC and pBluescript, by approximately 4-fold (compared to the XL1-Blue strain) and the ABLE K strain reduces the copy number of these plasmids approximately 10-fold. 

0.0/5.0
|0 Reviews

AD-293 Cells

Agilent Technologies

The AdEasy system saves you a month of work over traditional methods by producing the recombinant adenoviral plasmid by homologous recombination in E. coli. 

0.0/5.0
|0 Reviews

ArcticExpress (DE3) Competent Cells

Agilent Technologies

ArcticExpress Competent Cells are engineered to address the common bacterial gene expression hurdle of protein insolubility. These cells are derived from the high-performance Stratagene BL21-Gold competent cells, enabling efficient high-level expression of heterologous proteins in E. coli.

0.0/5.0
|0 Reviews



ArcticExpress Competent Cells

Agilent Technologies

ArcticExpress Competent Cells are engineered to address the common bacterial gene expression hurdle of protein insolubility. These cells are derived from the high-performance Stratagene BL21-Gold competent cells, enabling efficient high-level expression of heterologous proteins in E. coli.

0.0/5.0
|0 Reviews



BacterioMatch II Electrocompetent Reporter Cells

Agilent Technologies

The exclusive BacterioMatch II two-hybrid system is an efficient method for detecting protein-protein interactions in vivo. The BacterioMatch II system offers the ability to screen libraries for harder-to-find binding partners with reduced background.  Fast results  Bacterial transformation - no new techniques to learn  Readily detect protein-protein interactions  Convenient dual reporter to validate putative positives…

0.0/5.0
|0 Reviews

BacterioMatch II Screening Reporter Competent Cells

Agilent Technologies

The exclusive BacterioMatch II two-hybrid system is an efficient method for detecting protein-protein interactions in vivo. The BacterioMatch II system offers the ability to screen libraries for harder-to-find binding partners with reduced background.  Fast results  Bacterial transformation - no new techniques to learn  Readily detect protein-protein interactions  Convenient dual reporter to validate putative positives…

0.0/5.0
|0 Reviews

BacterioMatch II Validation Reporter Competent Cells

Agilent Technologies

The exclusive BacterioMatch II two-hybrid system is an efficient method for detecting protein-protein interactions in vivo. The BacterioMatch II system offers the ability to screen libraries for harder-to-find binding partners with reduced background.  Fast results  Bacterial transformation - no new techniques to learn  Readily detect protein-protein interactions  Convenient dual reporter to validate putative positives…

0.0/5.0
|0 Reviews

BJ5183 Electroporation-Competent Cells

Agilent Technologies

The AdEasy system saves you a month of work over traditional methods by producing the recombinant adenoviral plasmid by homologous recombination in E. coli. The AdEasy XL system includes BJ5183 cells pre-transformed with the pAdEasy-1 plasmid, this feature dramatically decreases background caused by the non-recombinant shuttle plasmid.

0.0/5.0
|0 Reviews

BJ5183-AD-1 Electroporation Competent Cells

Agilent Technologies

The AdEasy system saves you a month of work over traditional methods by producing the recombinant adenoviral plasmid by homologous recombination in E. coli. The AdEasy XL system includes BJ5183 cells pre-transformed with the pAdEasy-1 plasmid, this feature dramatically decreases background caused by the non-recombinant shuttle plasmid.

0.0/5.0
|0 Reviews